Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Scientific articles 14 Jun 2021 Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: A prospective, multicentre, open-label, cohort study The Lancet Global Health
Scientific articles 11 Jun 2021 How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? PLOS Neglected Tropical Diseases
Scientific articles 9 Jun 2021 Geographical variability in paromomycin pharmacokinetics does not explain efficacy differences between Eastern African and Indian visceral leishmaniasis patients Clinical Pharmacokinetics
Scientific articles 6 Jun 2021 Serological reactivity against T. cruzi-derived antigens: evaluation of their suitability for the assessment of response to treatment in chronic Chagas disease Acta Tropica
Scientific articles 3 Jun 2021 Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment EClinicalMedicine
Scientific articles 21 May 2021 Urgent needs to accelerate the race for COVID-19 therapeutics EClinicalMedicine
Scientific articles 14 May 2021 Open-Source Hardware, exploring how industry regulation affects knowledge commons governance: An exploratory case study International Journal of the Commons
Scientific articles 6 May 2021 Priorities for COVID-19 research response and preparedness in low-resource settings The Lancet
Scientific articles 30 Apr 2021 Preclinical and clinical characteristics of the trichuricidal drug oxantel pamoate and clinical development plans: A review Drugs
Scientific articles 23 Apr 2021 Supporting drug development for neglected tropical diseases using mathematical modeling Clinical Infectious Diseases
Scientific articles 22 Apr 2021 In vitro susceptibility to miltefosine of Leishmania infantum (syn. L. chagasi) isolates from different geographical areas in Brazil Microorganisms
Scientific articles 15 Apr 2021 Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial The Lancet Gastroenterology and Hepatology
Scientific articles 14 Apr 2021 The multidimensional comprehension of Chagas disease. Contributions, approaches, challenges and opportunities from and beyond the Information, Education, and Communication field Memorias do Instituto Oswaldo Cruz
Scientific articles 14 Apr 2021 The translational challenge in Chagas disease drug development Memorias do Instituto Oswaldo Cruz
Scientific articles 14 Apr 2021 Critical analysis of Chagas disease treatment in different countries Memorias do Instituto Oswaldo Cruz